tahiti pharm ste group

Activity value 79 united states Buyer,Last transaction date: 2026-05-28

Bill of lading data

< 1/15 >
  • Trade date 2026/05/28 B/L No. mfusbl26120085
  • Suppliers continental pharmaceutique Buyers tahiti pharm ste group
  • POLs 42737, le havre PODs 1001, new york, ny
  • Supply area France Purchas area United States
  • Weight 9247kg Amount 184940
  • Hs code 300490 Product tags dosage form,hyaluronicacid,gant,sodium,antigen,hyaluronic acid,salt,t s s,ail,medica,ronic,rits,dos,medicament,iu,acid,sodium salt
  • Product description MEDICAMENTS CONTAINING ANTIGENS OR HYALURONICACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FO RM OR PACKED FOR RETAILMEDICAMENTS CONTAININGANTIGENS OR HYALURONIC ACID OR ITS SODIUM SA LT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE F ORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RET AILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGEFORM OR PACKED FOR RETAILMEDICAMENTS CONTAIN ING ANTIGENS OR HYALURONIC ACID OR ITS SODIUMSALT, NESOI, IN DOSAGE FORM OR PACKED FOR RE TAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAI NING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYAL URONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FORRETAILMEDICAMENTS CONTAINING ANTIGENS OR HYA LURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SO DIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, INDOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITSSODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, I N DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTSCONTAINING ANTIGENS OR HYALURONIC ACID OR IT S SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENT S CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI,IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMEN TS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI , IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID ORITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PA CKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID O R ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NESOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HYALURONIC ACID OR ITS SODIUM SALT, NE SOI, IN DOSAGE FORM OR PACKED FOR RETAILMEDICAMENTS CONTAINING ANTIGENS OR HY Expand
+View All

Partners

Total 3
  • Rank Company Transactions Per Detail
  • 1 continental pharmaceutique francesupplier,they trade on 2026-05-28 376 99.21% >
  • 2 sdv li rouen francesupplier,they trade on 2015-03-26 2 0.53% >
  • 3 sdv li francesupplier,they trade on 2015-03-26 1 0.26% >

Products

Total 129
  • Products Transactions Per Detail
  • cod
    12 57.14% >
  • e 30
    12 57.14% >
  • freight prepaid
    12 57.14% >
  • hetero
    11 52.38% >
  • pharmaceutical product
    11 52.38% >
  • +View All

Hscode rank

Total 20
  • HSCode Name Transactions Per Detail
  • HS 300490 20 95.24% >
  • HS 290512 1 4.76% >

Trading Area

Total 4
  • Area Transactions Per Detail
  • france 289 76.25% >
  • other 70 18.47% >
  • costa rica 18 4.75% >
  • china 2 0.53% >

Port statistics

Total 4
  • Port Name Transactions Per Detail
  • new york 141 37.20% >
  • newark nj 72 19.00% >
  • 1001, new york, ny 29 7.65% >
  • 4601, new york/newark area, newark, nj 24 6.33% >
tahiti pharm ste group is united states Buyer,  and primarily engages in the import and export business of products such as cod,e 30,freight prepaid.  According to the 52wmb.com global trade database, as of 2026-05-28, the company has completed 379 international trades,  with its main trading regions covering france,other,costa rica etc.  The core products include HS300490,HS290512 etc,  often transported via new york,port newark nj, port 1001, new york, ny etc,  and its main trading partners are continental pharmaceutique,sdv li rouen,sdv li.  These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.  They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development. They provide reliable support for cross-border trade decision-making.
The trade data displayed on tahiti pharm ste group is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis. We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.

Reference contact info


Email Hunting Tool

Whatsapp:+8616621075894(9:00 Am-18:00 Pm (SGT))

About us Contact us Advertise Buyer Supplier Company report Industry report

©2010-2026 52wmb.com all rights reserved